title: Comment on: incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab.
authors.forename: Domenico
authors.initials: D
authors.lastname: Errante
authors.forename: Daniele
authors.initials: D
authors.lastname: Bernardi
authors.forename: Antonio
authors.initials: A
authors.lastname: Bianco
authors.forename: Luigi
authors.initials: L
authors.lastname: Salvagno
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D013997:Time Factors; D000068878:Trastuzumab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab